One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation : ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial

• Masahiro Natsuaki

• Takeshi Morimoto

• Erika Yamamoto

• Hiroki Shiomi

• Yutaka Furukawa

• Mitsuru Abe

• Koichi Nakao

• Tetsuya Ishikawa

• Kazuya Kawai

• Kei Yunoki

• Shogo Shimizu

• Masaharu Akao

• Shinji Miki

• Masashi Yamamoto

• Hisayuki Okada

• Kozo Hoshino

• Kazushige Kadota

• Yoshihiro Morino

• Keiichi Igarashi

• Kengo Tanabe

• Ken Kozuma

• Takeshi Kimura

Journal

• Cardiovascular intervention and therapeutics / Japanese Association of Cardiovascular Intervention and Therapeutics [編]

  Cardiovascular intervention and therapeutics / Japanese Association of Cardiovascular Intervention and Therapeutics [編] 31 (3), 196-209, 2016-07

  Tokyo : Springer Japan

Keywords

• Dual antiplatelet therapy
• Everolimus-eluting stent
• Coronary artery disease
• Coronary stent

Details

• CRID: 1520010378611908480
• NII Article ID: 40020881728
• NII Book ID: AA12510961
• ISSN: 18684300
• NDL BIB ID: 027487520
• Web Site: https://ndlsearch.ndl.go.jp/books/R000000004-I027487520
• Web Site: https://search.jamas.or.jp/link/ui/2017073355
• Text Lang: en
• NDL Source Classification:
  • ZS21(科学技術--医学--内科学)
• Data Source:
  • NDL
  • CiNii Articles